Authors: Van de Werf, F Adgey, J Ardissino, D Armstrong, PW Aylward, P Barbash, G Betriu, A Binbrek, AS Califf, R Diaz, R Fanebust, R Fox, K Granger, C Heikkila, J Husted, S Jansky, P Langer, A Lupi, E Maseri, A Meyer, J Mlczoch, J Mocceti, D Myburgh, D Oto, A Paolasso, E Pehrsson, K Seabra-Gomes, R Soares-Piegas, L Sugrue, D Tendera, M Topol, E Toutouzas, P Vahanian, A Verheugt, F Wallentin, L White, H Berioli, S Bluhmki, E Brower, R Danays, T Fox, NL Girault, C Goetz, G Houbracken, K Jakob, H Kaye, J Sarelin, H Clow, FW Hacke, W von Kummer, L Lesaffre, E Bluhmki, E Bogaerts, K Munster, K Scheys, I Truyen, M Clow, FW Fox, KAA Brower, R Hallstrom, A Jones, D Maggioni, A Weaver, D

Citation: F. Van De Werf et al., Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial, LANCET, 354(9180), 1999, pp. 716-722

Authors: Van de Werf, F Cannon, CP Luyten, A Houbracken, K McCabe, CH Berioli, S Bluhmki, E Sarelin, H Wang-Clow, F Fox, NL Braunwald, E

Citation: F. Van De Werf et al., Safety assessment of single-bolus administration of TNK tissue-plasminogenactivator in acute myocardial infarction: The ASSENT-1 trial, AM HEART J, 137(5), 1999, pp. 786-791